rs4804311

This variant is located in the MYO1F gene.

GWAS Catalog Trait Associations (7)

Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.

body height

Allele G
OR 0.03
p 1.0e-72
N 5,314,291
Large GWAS
European, Hispanic or Latin American, East Asian, African unspecified, South Asian
Allele G
OR 0.02
p 2.0e-24
N 405,540
Large GWAS
European

total lipids in medium LDL

Zoodsma M et al. A genetic map of human metabolism across the allele frequency spectrum. Nature Genetics 57(10):2445-2455 (2025)
Allele G
OR 0.04
p 3.0e-20
N 450,015
Large GWAS
multi-ancestry

triglyceride measurement

Koskeridis F et al. Pleiotropic genetic architecture and novel loci for C-reactive protein levels. Nature Communications 13(1):6939 (2022)
Allele A
OR 0.04
p 5.0e-18
N 361,194
Large GWAS
European

high density lipoprotein cholesterol measurement

Koskeridis F et al. Pleiotropic genetic architecture and novel loci for C-reactive protein levels. Nature Communications 13(1):6939 (2022)
Allele A
OR 0.04
p 1.0e-17
N 361,194
Large GWAS
European

health trait

Allele A
OR 0.02
p 4.0e-16
N 405,979
Large GWAS
European

non-alcoholic fatty liver disease

Allele A
OR 0.06
p 4.0e-15
N 122,644
Large GWAS
European

ClinVar annotation

Benign★★★
3 submitters1 publication

not provided; Thymoma; Familial cancer of breast; Uveal melanoma; Malignant lymphoma, large B-cell, diffuse; Lymphoma; Uterine carcinosarcoma; Cholangiocarcinoma

View on ClinVar →

About MYO1F

Myosins are molecular motors that use the energy from ATP hydrolysis to generate force on actin filaments. The protein encoded by this gene is an unconventional myosin that may be involved in the intracellular movement of membrane-enclosed compartments. There is evidence to suggest that mutations in this gene can result in hearing loss. [provided by RefSeq, Jan 2017]

View all MYO1F variants →

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…